Welcome to our dedicated page for Warby Parker SEC filings (Ticker: WRBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Warby Parker reimagined eyewear retail with its direct-to-consumer model and “Buy a Pair, Give a Pair” mission, but the company’s disclosures are just as multifaceted. Investors looking for Warby Parker SEC filings explained simply can uncover how store expansion, tele-optometry services, and social-impact costs shape margins and cash flow.
Stock Titan’s AI-powered dashboard turns dense documents into insight. Whether you need the Warby Parker annual report 10-K simplified to see unit economics, or a Warby Parker quarterly earnings report 10-Q filing to gauge same-store sales, our platform delivers. Real-time alerts flag Warby Parker Form 4 insider transactions real-time, so you never miss Warby Parker insider trading Form 4 transactions. For quick answers try: understanding Warby Parker SEC documents with AI—our summaries spotlight segment revenue, inventory turns, and customer acquisition spend in seconds.
Use cases stretch from headline checks to deep dives:
- Warby Parker executive stock transactions Form 4 and ownership changes
- Warby Parker proxy statement executive compensation benchmarking
- Warby Parker 8-K material events explained for product launches or leadership shifts
- Warby Parker earnings report filing analysis comparing online versus store performance
Every filing type—10-K, 10-Q, 8-K, S-1, Section 16 forms—lands on Stock Titan within seconds of EDGAR release and is paired with concise AI commentary, red-flag detection, and keyword search. Save hours parsing optical-industry jargon and focus on decisions, not downloads.
Warby Parker (WRBY) insider activity: A Co‑Chief Executive Officer and director reported converting 125,000 shares of Class B common stock into Class A common stock at $0 and selling 125,000 Class A shares on 10/01/2025 under code S.
The sale was executed under a Rule 10b5‑1 trading plan adopted on March 14, 2025, at an average price of $27.30, with trades ranging from $27.00 to $27.64. Following the transactions, the filer directly held 32,861 Class A shares, 5,088,920 derivative securities linked to Class B, and 1,656,770 Class A shares indirectly via the David A. Gilboa 2012 Family Trust. Class B is convertible into Class A on a one‑to‑one basis per the company’s dual‑class structure.
Warby Parker Inc. (WRBY) reporting person David A. Gilboa disclosed insider transactions on 09/17/2025 and 09/18/2025. The filing shows conversions and sales executed pursuant to a Rule 10b5-1 trading plan adopted March 14, 2025. On 09/17/2025 he converted 600 shares (Code C) and sold 600 Class A shares at an average price of $27.52, leaving 32,861 Class A shares directly owned. On 09/18/2025 he converted 58,360 shares and sold 58,360 Class A shares at an average price of $27.58, resulting in 32,861 Class A shares directly owned after the transactions. The derivative table shows large Class B holdings convertible one-for-one into Class A, and an indirect holding of 1,656,770 Class A-equivalent shares held by the David A. Gilboa 2012 Family Trust.
Neil Blumenthal, Co-Chief Executive Officer and director of Warby Parker Inc. (WRBY), reported multiple transactions under a Rule 10b5-1 plan. On 09/17/2025 he purchased 500 Class A shares and sold 500 Class A shares at an average price of $27.52. On 09/18/2025 he purchased 8,416 Class A shares and sold 8,416 Class A shares at an average price of $27.52. After these trades he directly beneficially owns 32,733 Class A shares.
The filing also reports 200,000 Class A shares held indirectly each by Royal Blue Aries Trust and Tiffany Blue Gemini Trust, and multiple holdings of Class B convertible shares held indirectly across several trusts and family entities, including 1,548,334 Class A-equivalent shares by the 2011 Family Trust.
Warby Parker Inc. (WRBY) filing a Form 144 notifies a proposed sale of 175,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $4,681,250 and an approximate sale date of 09/18/2025 on the NYSE. The securities were acquired on 06/28/2017 via previously exercised stock options and paid in cash. The filing also discloses prior sales by related parties and 10b5-1 plans totaling 316,640 shares sold in the past three months for gross proceeds of about $8.09 million, showing ongoing insider disposition activity.
David A. Gilboa, Co‑CEO and director of Warby Parker Inc. (WRBY), reported preplanned sales under a Rule 10b5‑1 plan. On 09/11/2025 he purchased 41,040 shares of Class A common stock at $0 (conversion of Class B into A) and sold 41,040 shares of Class A common stock at an average execution price of $27.53, in multiple transactions priced between $27.50 and $27.59. Following these transactions he directly beneficially owned 32,861 shares and indirectly owned 1,656,770 shares through the 2012 Family Trust. The report states the Class B shares convert one‑for‑one into Class A shares under specified conditions and that the sales were effected pursuant to a 10b5‑1 plan adopted March 14, 2025.
Neil H. Blumenthal, Co‑Chief Executive Officer and director of Warby Parker Inc. (WRBY), reported transactions dated 09/11/2025. He converted 41,084 Class B shares into Class A common stock (reported as Code C) and sold those 41,084 Class A shares under a Rule 10b5‑1 trading plan at an average execution price of $27.53 per share. Following these transactions, he directly beneficially owned 73,817 Class A shares and, through various trusts, beneficial indirect ownership totaling multiple Class A equivalent share blocks (for example, 200,000 by each of two trusts). The filing notes the 10b5‑1 plan was adopted on March 14, 2025, and sale prices ranged from $27.50 to $27.59.
Form 144 for Warby Parker (WRBY) reports a proposed sale of 50,000 common shares, to be executed through Morgan Stanley Smith Barney on 09/11/2025, with an aggregate market value of $1,350,500. The shares were acquired on 12/04/2019 from previously exercised stock options. The filing shows 105,187,778 shares outstanding. Recent disclosures list three Rule 10b5-1 sales by Neil Harris Blumenthal totaling 100,000 shares in July–August 2025 with gross proceeds of approximately $3,461,670.24. The filer affirms no undisclosed material information and includes the standard Rule 144 representation.
Form 144 notice for Warby Parker Inc. (WRBY) shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,350,500 and an approximate sale date of 09/11/2025. The shares were acquired on 06/28/2017 via previously exercised stock options. The filing reports 105,187,778 shares outstanding. The document also discloses three Rule 10b5-1 sales attributed to David Gilboa in the past three months: 74,500 shares on 07/21/2025 for $1,808,047.95, 500 shares on 07/18/2025 for $12,006.00, and 50,000 shares on 07/01/2025 for $1,101,870.00. The filer certifies absence of undisclosed material adverse information.
Joel E. Cutler, a director of Warby Parker Inc. (WRBY), reported multiple changes in beneficial ownership on 09/08/2025. The filing shows dispositions and transfers of Class A common stock between Cutler, a revocable trust and the Randi & Joel Cutler Family Foundation, and a sale to third parties. Specifically, 35,000 shares were recorded as disposed under Code G with $0 consideration and an aggregate 108,572 shares were noted as previously distributed to the Joel E Cutler Revocable Trust effective March 20, 2025, exempt from Section 16 rules. The report also records an acquisition of 35,000 Class A shares at $0 by the Randi & Joel Cutler Family Foundation and a sale of 35,000 shares at a weighted average price of $26.7529, producing 19,932 shares beneficially owned by the Foundation after the transactions.
Warby Parker (WRBY) Form 144 filing: The filer notifies a proposed sale of 35,000 Class A common shares through Goldman Sachs & Co. LLC on 09/08/2025. The filing reports an aggregate market value of $936,250 and notes 105,187,778 shares outstanding. The shares were reported as acquired as a gift from the Joel Cutler Revocable Trust; the trust acquired the shares on 09/29/2021. The form states there were no securities sold in the past three months for the account and includes the standard attestation that the seller is unaware of undisclosed material adverse information.